Contextual Genomics raises $12 mln facility from PacBridge
Vancouver-based cancer genomics company Contextual Genomics Inc has secured $12 million in a facility provided by PacBridge Capital Partners (HK), a Hong Kong growth-stage investment firm. PacBridge's James Lumsdaine will join the board as a result. Founded in 2012, Contextual is a developer of solutions that harness the clinical and genomic data of cancer patients to improve diagnosis and present expanded treatment options. The funds raised will be used for global distribution of FIND IT, a molecular hotspot assay, and development of FOLLOW IT, a mutation detection assay. Contextual is led by Executive Chairman Chris Wagner.
26 February 2018•4 mins read
